Annual CFF
$41.95 M
-$125.14 M-74.89%
31 December 2023
Summary:
Terns Pharmaceuticals annual cash flow from financing activities is currently $41.95 million, with the most recent change of -$125.14 million (-74.89%) on 31 December 2023. During the last 3 years, it has fallen by -$43.56 million (-50.94%). TERN annual CFF is now -74.89% below its all-time high of $167.09 million, reached on 31 December 2022.TERN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$163.29 M
+$162.89 M+40825.31%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly cash flow from financing activities is currently $163.29 million, with the most recent change of +$162.89 million (+40825.31%) on 30 September 2024. Over the past year, it has increased by +$163.27 million (+816360.00%). TERN quarterly CFF is now at all-time high.TERN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$177.55 M
+$163.27 M+1143.28%
30 September 2024
Summary:
Terns Pharmaceuticals TTM cash flow from financing activities is currently $177.55 million, with the most recent change of +$163.27 million (+1143.28%) on 30 September 2024. Over the past year, it has increased by +$43.49 million (+32.44%). TERN TTM CFF is now -19.56% below its all-time high of $220.72 million, reached on 31 March 2021.TERN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.9% | +10000.0% | +32.4% |
| 3 y3 years | -50.9% | +10000.0% | -12.5% |
| 5 y5 years | -58.0% | - | - |
TERN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.9% | at low | at high | -12.5% | >+9999.0% | |
| 5 y | 5 years | -74.9% | >+9999.0% | at high | >+9999.0% | -19.6% | >+9999.0% |
| alltime | all time | -74.9% | >+9999.0% | at high | >+9999.0% | -19.6% | >+9999.0% |
Terns Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $163.29 M(>+9900.0%) | $177.55 M(+1143.3%) |
| June 2024 | - | $399.00 K(>+9900.0%) | $14.28 M(-0.6%) |
| Mar 2024 | - | $0.00(-100.0%) | $14.37 M(-65.7%) |
| Dec 2023 | $41.95 M(-74.9%) | $13.86 M(>+9900.0%) | $41.95 M(-68.7%) |
| Sept 2023 | - | $20.00 K(-95.9%) | $134.06 M(-31.3%) |
| June 2023 | - | $489.00 K(-98.2%) | $195.04 M(+0.2%) |
| Mar 2023 | - | $27.58 M(-74.0%) | $194.68 M(+16.5%) |
| Dec 2022 | $167.09 M | $105.97 M(+73.7%) | $167.09 M(+173.3%) |
| Sept 2022 | - | $61.00 M(>+9900.0%) | $61.14 M(+6425.2%) |
| June 2022 | - | $124.00 K(>+9900.0%) | $937.00 K(-220.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) | -$776.00 K(-100.6%) |
| Dec 2021 | $134.39 M(+57.2%) | $16.00 K(-98.0%) | $134.39 M(-33.8%) |
| Sept 2021 | - | $797.00 K(-150.2%) | $203.02 M(+0.4%) |
| June 2021 | - | -$1.59 M(-101.2%) | $202.25 M(-8.4%) |
| Mar 2021 | - | $135.17 M(+96.9%) | $220.72 M(+158.1%) |
| Dec 2020 | $85.52 M(>+9900.0%) | $68.64 M(>+9900.0%) | $85.52 M(+406.8%) |
| Sept 2020 | - | $32.00 K(-99.8%) | $16.88 M(+0.2%) |
| June 2020 | - | $16.88 M(<-9900.0%) | $16.84 M(<-9900.0%) |
| Mar 2020 | - | -$33.00 K | -$33.00 K |
| Dec 2019 | $62.00 K(-99.9%) | - | - |
| Dec 2018 | $99.76 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual CFF year-on-year change?
- What is Terns Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly CFF year-on-year change?
- What is Terns Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM CFF year-on-year change?
What is Terns Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of TERN is $41.95 M
What is the all time high annual CFF for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual cash flow from financing activities is $167.09 M
What is Terns Pharmaceuticals annual CFF year-on-year change?
Over the past year, TERN annual cash flow from financing activities has changed by -$125.14 M (-74.89%)
What is Terns Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of TERN is $163.29 M
What is the all time high quarterly CFF for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly cash flow from financing activities is $163.29 M
What is Terns Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, TERN quarterly cash flow from financing activities has changed by +$163.27 M (+816360.00%)
What is Terns Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of TERN is $177.55 M
What is the all time high TTM CFF for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM cash flow from financing activities is $220.72 M
What is Terns Pharmaceuticals TTM CFF year-on-year change?
Over the past year, TERN TTM cash flow from financing activities has changed by +$43.49 M (+32.44%)